TEST CATALOG ORDERING & RESULTS SPECIMEN HANDLING CUSTOMER SERVICE EDUCATION & INSIGHTS
Test Catalog

Test ID: HCCGS    
Hepatocellular Carcinoma Risk Panel with GALAD Score, Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

Risk assessment for development of hepatocellular carcinoma in patients with chronic liver disease

Highlights

This test includes a GALAD (gender, age, alpha-fetoprotein [AFP]-L3, AFP, des-gamma-carboxy prothrombin [DCP]) model score calculation to calculate the probability of hepatocellular carcinoma (HCC). The GALAD model has been demonstrated to have higher diagnostic accuracy for the detection of HCC when compared to the use AFP, AFP-L3, and DCP markers alone or in combination. The performance of the GALAD score has also been reported to be superior to ultrasound for HCC detection.

Profile Information A profile is a group of laboratory tests that are ordered and performed together under a single Mayo Test ID. Profile information lists the test performed, inclusive of the test fee, when a profile is ordered and includes reporting names and individual availability.

Test IDReporting NameAvailable SeparatelyAlways Performed
L3AFPAFP-L3% and Total AFP, SYesYes
DCPDes-Gamma-Carboxy Prothrombin, SYesYes
GAL1GALAD Model ScoreNoYes
GAL2Probability of HCCNoYes

Method Name A short description of the method used to perform the test

Isotachophoresis with Laser-Induced Fluorescence

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

HCC Risk Panel with GALAD Score, S